TADASIVA – potency remedy | Buy in Ukraine with delivery

What is TADASIVA?

TADASIVA is a combination medicinal product belonging to the pharmacological group of agents for the treatment of erectile dysfunction and symptoms of benign prostatic hyperplasia. The main purpose of the drug is to restore natural erectile function in men who experience difficulty in achieving or maintaining an erection sufficient for satisfactory sexual intercourse. TADASIVA is available in the form of film-coated tablets, which protects the active substance from degradation in the stomach and promotes uniform absorption into the bloodstream. The drug is manufactured in compliance with international quality standards, guaranteeing dose consistency and a predictable therapeutic effect with each use. Each tablet contains a precisely calibrated amount of the active substance, allowing the physician to individually select the optimal dose for a specific patient.

The pharmacological action of TADASIVA is based on the selective inhibition of the type 5 phosphodiesterase enzyme, which is responsible for the breakdown of cyclic guanosine monophosphate in the cavernous bodies of the penis. Thanks to this mechanism, relaxation of the vascular smooth muscle occurs, arterial blood flow to the erectile tissue increases, and a stable erection develops in response to sexual stimulation. It is important to understand that TADASIVA does not cause an erection without natural sexual excitement; it merely enhances the body's physiological response to stimulation. The drug does not affect libido, does not alter hormonal levels, and has no psychostimulating effect, making it safe for long-term use as prescribed by a doctor. The therapeutic effect develops gradually and can persist for a long period after taking the tablet.

A specific feature of TADASIVA is the extended half-life of its active substance, which ensures the possibility of a spontaneous sexual life without a strict linkage to the time of drug ingestion. This characteristic distinguishes the medication favorably from short-acting agents that require planning sexual intercourse within a narrow time window. TADASIVA allows a man to maintain natural intimate relationships while reducing the psychological pressure associated with the need for precise time calculation. The drug is intended exclusively for adult men aged 18 and older and is available by prescription, underscoring the necessity of a preliminary medical examination before starting therapy. Self-treatment of erectile dysfunction can mask serious cardiovascular diseases; therefore, consulting a specialist is mandatory.

What is TADASIVA prescribed for?

The main indication for prescribing TADASIVA is erectile dysfunction of various origins, characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. This condition can be caused by psychogenic factors, such as stress, anxiety, or depressive disorders, as well as organic causes, including vascular atherosclerosis, diabetes mellitus, hypertension, and the consequences of surgical interventions on the pelvic organs. TADASIVA is effective in mixed forms of erectile dysfunction, where psychological and somatic components of the disorder are combined. The drug helps restore self-confidence and improve the quality of intimate life, which positively affects the patient's overall psycho-emotional state.

The second important indication is the symptomatic treatment of benign prostatic hyperplasia, also known as prostate adenoma. In this disease, TADASIVA promotes the relaxation of the smooth muscle of the prostate gland and the bladder neck, facilitating urination and reducing such uncomfortable symptoms as frequent urination, nocturnal urges, a sensation of incomplete bladder emptying, and a weak urine stream. The drug can be used as monotherapy or in combination with alpha-blockers, depending on the clinical situation and the urologist's recommendations. Such a dual mechanism of action makes TADASIVA especially valuable for patients in whom erectile dysfunction is combined with lower urinary tract symptoms.

TADASIVA is also prescribed in cases where long-term therapy with a flexible dosing regimen is required, as the drug can be used both on an as-needed basis and as a daily low-dose regimen. The daily regimen is particularly suitable for men who lead an active sex life and do not wish to plan each sexual act separately. Furthermore, regular intake of low doses of TADASIVA provides a constant concentration of the active substance in the blood, allowing for a stable therapeutic effect and improving the spontaneity of intimate relations. The choice of dosing regimen is always made individually by a physician, taking into account the frequency of sexual activity, the severity of the disorder, and the presence of concomitant diseases.

Composition and active components of TADASIVA

The main active ingredient of TADASIVA is tadalafil, which belongs to the class of selective phosphodiesterase type 5 inhibitors. Tadalafil blocks the enzyme that breaks down cyclic guanosine monophosphate in the vascular smooth muscle cells of the penis, resulting in an increased concentration of this signaling molecule. Elevated levels of cyclic guanosine monophosphate lead to relaxation of the vascular wall, dilation of the arteries, and increased blood filling of the cavernous bodies, which provides the onset and maintenance of an erection. Tadalafil has the longest half-life among all drugs in this group, which is approximately 17.5 hours, providing a duration of action of up to 36 hours after a single dose.

The excipients of TADASIVA include lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, and other substances that ensure the stability of the tablet, its proper mechanical strength, and uniform release of the active substance in the gastrointestinal tract. The film coating protects tadalafil from premature degradation and facilitates swallowing of the tablet. Each excipient performs a specific function: microcrystalline cellulose acts as a filler and binder, croscarmellose sodium promotes rapid disintegration of the tablet after entering the stomach, and magnesium stearate prevents the powder mass from sticking to the compressing equipment during production.

The mechanism of action of tadalafil is highly selective, as it inhibits phosphodiesterase type 5 to a significantly greater extent compared to other isoforms of this enzyme present in the heart, brain, kidneys, and other organs. Such selectivity ensures minimal impact on other physiological processes and reduces the risk of systemic side effects. It is important to note that tadalafil does not directly affect smooth muscle without prior activation of the nitric oxide pathway, which occurs only under the condition of sexual stimulation. This means that the drug does not cause spontaneous erections at rest and does not disrupt the normal physiological regulation of erectile function.

TADASIVA Dosage

The standard recommended dose of TADASIVA for most patients is 10 mg on an as-needed basis, taken approximately 30–60 minutes before anticipated sexual activity. Depending on individual sensitivity and the magnitude of the therapeutic effect, the dose may be increased to 20 mg or decreased to 5 mg. The maximum recommended dosing frequency for the "on-demand" regimen is once daily, as exceeding this frequency does not increase efficacy but significantly raises the risk of adverse reactions. The doctor determines the optimal dose based on an evaluation of the patient's response to previous doses of the drug, the presence of comorbid conditions, and other medications the patient takes regularly.

For patients who prefer a regular sex life without planning, daily intake of TADASIVA at a dose of 5 mg at the same time of day is recommended. This regimen maintains a constant therapeutic concentration of tadalafil in the blood plasma, allowing an erection to be achieved at any moment in the presence of sexual stimulation. Daily use is particularly suitable for men who engage in sexual activity more than twice a week, as well as for patients with concomitant symptoms of benign prostatic hyperplasia. With daily use, a steady-state concentration of the drug is reached after 5–7 days of regular intake, after which the therapeutic effect becomes continuous and independent of the time of the last tablet taken.

Dose adjustment of TADASIVA may be required for patients with impaired renal or hepatic function, as tadalafil is metabolized primarily in the liver and excreted from the body via the kidneys. In severe renal impairment, the maximum recommended on-demand dose should not exceed 10 mg, and daily intake at a dose of 5 mg may be contraindicated. In patients with severe hepatic impairment, the drug is prescribed with special caution after a careful evaluation of the benefit-risk ratio. Elderly patients usually do not require dose adjustment; however, a potential decline in renal function and increased sensitivity to the drug's action should be taken into account.

How to take TADASIVA correctly?

TADASIVA is taken orally regardless of food intake, as taking the medication with food does not significantly affect its absorption and bioavailability. The tablet should be swallowed whole, without chewing or crushing, with a sufficient amount of water. Unlike some other drugs in this class, consuming fatty foods does not reduce the efficacy of TADASIVA, so the patient does not need to restrict dietary intake before administration. However, excessive alcohol consumption can impair the ability to achieve an erection and increase the risk of orthostatic hypotension; therefore, it is recommended to limit alcohol consumption during therapy.

When using TADASIVA on an "as-needed" schedule, the drug should be taken at least 30 minutes before planned sexual activity, although the therapeutic effect can persist for up to 36 hours after ingestion. This means that the patient is not required to precisely time sexual intercourse and can feel free in choosing the moment for intimacy. If a patient forgets to take a tablet on the daily regimen, the missed dose should be taken as soon as possible, but the next dose should not be doubled to compensate for the missed one. Consistency of intake under the daily schedule is a key factor in maintaining a stable blood concentration of the drug and achieving a sustained therapeutic effect.

Before starting TADASIVA, it is necessary to undergo a complete medical examination, including an evaluation of the cardiovascular system, as sexual activity itself poses an additional strain on the heart. Patients with heart disease who have recently suffered a myocardial infarction or stroke should refrain from using the drug until consulting a cardiologist. It is also important to inform the doctor about all medications the patient takes on a regular basis, as certain combinations can be dangerous. An individual's response to the drug may vary; therefore, the first intake is recommended in a calm environment with the opportunity to monitor one's well-being.

TADASIVA side effects

The most common side effects of TADASIVA are headache, dyspepsia, back pain, myalgia, nasal congestion, and facial flushing. These reactions are usually mild to moderate in severity, occur predominantly at the beginning of therapy, and gradually diminish with continued use of the drug. The headache is associated with the dilation of cerebral blood vessels due to phosphodiesterase inhibition, while nasal congestion arises from the dilation of blood vessels in the nasal mucosa. Muscle and back pain typically appear 12–24 hours after taking the dose and resolve spontaneously within 48–72 hours without additional treatment.

Uncommon adverse reactions include dizziness, palpitations, increased blood pressure, tinnitus, and visual disturbances, including altered color perception and increased sensitivity to light. These symptoms may indicate individual hypersensitivity to tadalafil or an interaction with other medicinal products. Rare but serious side effects include priapism—a prolonged and painful erection lasting more than 4 hours, sudden loss of vision or hearing, as well as severe allergic reactions, including angioedema. If priapism occurs, immediate medical attention is required, as the lack of timely treatment can lead to irreversible damage to penile tissue.

The patient should seek medical attention immediately if side effects do not disappear over a long period, worsen, or are accompanied by chest pain, shortness of breath, fainting, or other alarming symptoms. Particular attention should be paid to cardiovascular reactions, as patients with erectile dysfunction frequently have underlying cardiovascular diseases. The individual's response to TADASIVA may depend on age, liver and kidney condition, comorbid diseases, and genetic metabolic characteristics. Therefore, it is important to report any unusual symptoms that occur during therapy to the physician for timely dose adjustment or drug replacement.

TADASIVA Contraindications

An absolute contraindication to the use of TADASIVA is the concomitant administration of organic nitrates in any dosage form, as the combination of tadalafil with nitrates can cause a life-threatening drop in blood pressure. Nitrates are prescribed for the treatment of angina pectoris and ischemic heart disease; therefore, patients taking such medications must strictly avoid TADASIVA. The drug is also contraindicated in patients with known hypersensitivity to tadalafil or any of the excipients, which may manifest as allergic reactions of varying severity. Men for whom sexual activity is inadvisable due to severe cardiovascular disease, such as unstable angina, severe heart failure, or recent myocardial infarction, are prohibited from using the drug.

Relative contraindications include anatomical deformations of the penis, such as Peyronie's disease, cavernosal fibrosis, or penile angulation, as increased blood flow may cause pain and complications. For patients with conditions that predispose to priapism, including sickle cell anemia, leukemia, and multiple myeloma, TADASIVA is prescribed with extreme caution. The drug is not intended for use in women, children, and adolescents under 18 years of age, as safety and efficacy in these populations have not been established. The drug is not prescribed to pregnant or breastfeeding women, as it has no indications for use in the female population.

In patients with severe renal impairment, TADASIVA may be contraindicated or require a significant dose reduction depending on the clinical situation. In severe hepatic impairment, the drug is used only in cases where the expected benefit outweighs the potential risk, since tadalafil metabolism occurs primarily in the liver. Men who have lost vision in one eye due to non-arteritic anterior ischemic optic neuropathy should avoid using phosphodiesterase type 5 inhibitors, as there is a theoretical risk of damage to the second eye. Before initiating TADASIVA therapy, the physician must thoroughly take a history and evaluate all risk factors to make an informed decision regarding the safety of the drug's use.

Interaction of TADASIVA with other drugs and alcohol

TADASIVA can interact with alpha-blockers used to treat hypertension and benign prostatic hyperplasia, which can lead to an excessive drop in blood pressure and orthostatic hypotension. Particular caution should be exercised when combining tadalafil with doxazosin, tamsulosin, and other drugs in this group, initiating therapy with minimal doses and monitoring blood pressure. Inhibitors of the CYP3A4 enzyme, such as ketoconazole, itraconazole, ritonavir, and erythromycin, can increase tadalafil concentrations in the blood, requiring a reduction in the dose of TADASIVA to avoid overdose. CYP3A4 inducers, such as rifampicin, carbamazepine, and phenytoin, conversely, accelerate the metabolism of tadalafil and reduce its efficacy.

Alcohol consumption during TADASIVA therapy is not strictly prohibited; however, excessive consumption of alcoholic beverages can significantly increase the risk of orthostatic hypotension, dizziness, and headache. Alcohol itself suppresses erectile function, so combining it with the drug may reduce the expected therapeutic effect. It is recommended to limit alcohol consumption to minimal amounts or to abstain from it completely while taking TADASIVA. Regarding driving vehicles and operating machinery, the drug usually does not affect reaction speed; however, if dizziness or visual disturbances occur, one should refrain from such activities until the condition normalizes.

Where to buy TADASIVA in Ukraine

TADASIVA is available in pharmacy chains across Ukraine by prescription, which ensures controlled and safe use of the drug in accordance with medical indications. The purchase of the drug is possible both in physical pharmacies and through online medication reservation services, which allow ordering TADASIVA with delivery or pick-up from the nearest pharmacy. Before purchasing, it is recommended to check the availability of the drug in several pharmacy outlets, as availability may vary depending on the region and supplier. The price of TADASIVA may vary depending on the dosage, the number of tablets in the package, and the pricing policy of a specific pharmacy chain.

TADASIVA should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius, out of the reach of children. The shelf life of the drug is usually 2–3 years from the date of manufacture, after which the use of the tablets is strictly forbidden. Before using TADASIVA, it is imperative to consult a doctor who will conduct the necessary examination, determine the absence of contraindications, and prescribe the optimal dose taking into account the individual characteristics of the patient. Self-medication can be dangerous to health; therefore, a responsible attitude toward therapy is the key to its effectiveness and safety.